Skip to main content
Premium Trial:

Request an Annual Quote

Indiana Future Fund Invests Part of $73M In Life Sciences VCs

NEW YORK, April 12 (GenomeWeb News) - The Indiana Future Fund $73 million "fund of funds" in Indiana has invested a portion of its funds in four life sciences venture capital firms with offices in Indiana. The funds from this round are intended to be invested in Indiana-based life sciences companies.


The parties did not disclose the specific amount of the investment.


The Future Fund made the investments in REI, a joint venture of Rose-Hulman Ventures and EDF Ventures, both of which have offices in Terre Haute, Ind.; Pearl Street Venture Funds; A.M. Pappas & Associates; and Burrill & Company.


The Indiana Future Fund was assembled by BioCrossroads, an organization to promote life sciences investment in Indiana, and includes investments from the state's pension funds, Eli Lilly, Anthem Blue Cross and Blue Shield; Indiana University, Indiana University Foundation, Purdue University, Ball State University Foundation; American United Life Insurance Company, Indiana State University Foundation and Guidant Corporation.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.